Jaguar Animal Health Company Profile (NASDAQ:JAGX)

About Jaguar Animal Health (NASDAQ:JAGX)

Jaguar Animal Health logoJaguar Animal Health, Inc. is an animal health company. It is focused on developing and commercializing gastrointestinal products for companion and production animals, foals, and horses. Canalevia is its prescription drug product candidate, intended for treatment of various forms of diarrhea in dogs. Canalevia is a canine-specific formulation of crofelemer, an active pharmaceutical ingredient (API) isolated and purified from the Croton lechleri tree. It is developing a pipeline of prescription drug product candidates and non-prescription (non-drug) products to address needs in animal health. As of December 31, 2016, its pipeline includes prescription drug product candidates for nine indications across multiple species, and non-prescription products targeting seven species. Its product candidates include Canalevia, Species-specific formulations of crofelemer, Equilevia, Virend (topical), Species-specific formulations of NP-500, Neonorm Calf and Species-specific formulations of Neonorm.

Industry, Sector and Symbol: Capitalization:
  • Market Cap: $9.65 million
  • Outstanding Shares: 14,007,000
Average Prices:
  • 50 Day Moving Avg: $0.81
  • 200 Day Moving Avg: $0.83
  • 52 Week Range: $0.50 - $3.79
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -17.22
  • P/E Growth: 0.0000
Sales & Book Value:
  • Annual Revenue: $141,523.00
  • Price / Sales: 68.18
  • Book Value: ($0.18) per share
  • Price / Book: -3.94
Profitability:
  • EBIDTA: ($13,550,000.00)
  • Net Margins: -9,095.21%
  • Return on Equity: -588.64%
  • Return on Assets: -165.66%
Debt:
  • Debt-to-Equity Ratio: -8.41%
  • Current Ratio: 1.32%
  • Quick Ratio: 1.23%
Misc:
  • Average Volume: 514,648 shs.
  • Beta: -0.11
  • Short Ratio: 2.06
 

Frequently Asked Questions for Jaguar Animal Health (NASDAQ:JAGX)

What is Jaguar Animal Health's stock symbol?

Jaguar Animal Health trades on the NASDAQ under the ticker symbol "JAGX."

How were Jaguar Animal Health's earnings last quarter?

Jaguar Animal Health Inc (NASDAQ:JAGX) issued its quarterly earnings data on Monday, November, 14th. The company reported ($0.30) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.40) by $0.10. The firm had revenue of $0.05 million for the quarter, compared to the consensus estimate of $0.10 million. Jaguar Animal Health had a negative net margin of 9,095.21% and a negative return on equity of 588.64%. View Jaguar Animal Health's Earnings History.

Where is Jaguar Animal Health's stock going? Where will Jaguar Animal Health's stock price be in 2017?

1 brokerages have issued 12 month price targets for Jaguar Animal Health's shares. Their forecasts range from $10.00 to $10.00. On average, they expect Jaguar Animal Health's share price to reach $10.00 in the next twelve months. View Analyst Ratings for Jaguar Animal Health.

Who are some of Jaguar Animal Health's key competitors?

When did Jaguar Animal Health IPO?

(JAGX) raised $22 million in an IPO on Wednesday, May 13th 2015. The company issued 3,200,000 shares at $7.00 per share. Aegis Capital Corp served as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.

Who owns Jaguar Animal Health stock?

Jaguar Animal Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Kingdon Capital Management L.L.C. (9.27%) and Vanguard Group Inc. (0.83%). View Institutional Ownership Trends for Jaguar Animal Health.

Who bought Jaguar Animal Health stock? Who is buying Jaguar Animal Health stock?

Jaguar Animal Health's stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc.. View Insider Buying and Selling for Jaguar Animal Health.

How do I buy Jaguar Animal Health stock?

Shares of Jaguar Animal Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Jaguar Animal Health stock cost?

One share of Jaguar Animal Health stock can currently be purchased for approximately $0.69.

Analyst Ratings

Consensus Ratings for Jaguar Animal Health (NASDAQ:JAGX) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00 (1,351.59% upside)

Analysts' Ratings History for Jaguar Animal Health (NASDAQ:JAGX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/13/2016AegisReiterated RatingBuy$10.00N/AView Rating Details
3/30/2016Feltl & Co.DowngradeStrong-Buy -> BuyN/AView Rating Details
(Data available from 5/26/2015 forward)

Earnings

Earnings History for Jaguar Animal Health (NASDAQ:JAGX)
Earnings by Quarter for Jaguar Animal Health (NASDAQ:JAGX)
Earnings History by Quarter for Jaguar Animal Health (NASDAQ:JAGX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/20169/30/2016($0.40)($0.30)$0.10 million$0.05 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Jaguar Animal Health (NASDAQ:JAGX)
2017 EPS Consensus Estimate: ($1.09)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.21)($0.21)($0.21)
Q2 20171($0.28)($0.28)($0.28)
Q3 20171($0.30)($0.30)($0.30)
Q4 20171($0.30)($0.30)($0.30)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Jaguar Animal Health (NASDAQ:JAGX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Jaguar Animal Health (NASDAQ:JAGX)
Insider Ownership Percentage: 22.90%
Institutional Ownership Percentage: 22.46%
Insider Trades by Quarter for Jaguar Animal Health (NASDAQ:JAGX)
Institutional Ownership by Quarter for Jaguar Animal Health (NASDAQ:JAGX)
Insider Trades by Quarter for Jaguar Animal Health (NASDAQ:JAGX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/8/2016James J BochnowskiDirectorBuy160,000$2.50$400,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Jaguar Animal Health (NASDAQ:JAGX)
Latest Headlines for Jaguar Animal Health (NASDAQ:JAGX)
Source:
DateHeadline
finance.yahoo.com logoLisa Conte, CEO of Jaguar Animal Health and Napo Pharmaceuticals, to Present at the Southern California Investment Forum May 31, 2017 in Los Angeles
finance.yahoo.com - May 26 at 2:38 AM
finance.yahoo.com logoNapo Pharmaceuticals’ New Mytesi Video Calls Attention to the Continuing Widespread Problem of Diarrhea in People Living With HIV/AIDS
finance.yahoo.com - May 24 at 11:24 AM
seekingalpha.com logoJaguar Animal Health (JAGX)
seekingalpha.com - May 19 at 5:44 PM
finance.yahoo.com logoJaguar Animal Health and Napo Pharmaceuticals Appoint Dr. Pravin Chaturvedi to Chair Scientific Advisory Board
finance.yahoo.com - May 10 at 1:13 PM
streetinsider.com logoJaguar Animal Health (JAGX) Signs Distribution Agreement for Neonorm Foal and Neonorm Calf in Japan
www.streetinsider.com - April 29 at 11:34 PM
americanbankingnews.com logoJaguar Animal Health (JAGX) Receives Daily News Sentiment Rating of 0.19
www.americanbankingnews.com - April 29 at 7:44 PM
reuters.com logoBRIEF-Jaguar signs distribution agreement JP Equine Services
www.reuters.com - April 28 at 9:47 AM
finance.yahoo.com logoJaguar Signs Distribution Agreement for Japan for Neonorm Foal & Neonorm Calf
finance.yahoo.com - April 28 at 9:47 AM
americanbankingnews.com logoJaguar Animal Health (JAGX) Given Media Impact Rating of 0.19
www.americanbankingnews.com - April 21 at 4:19 PM
seekingalpha.com logoJaguar Animal Health set to launch ad campaigns to support Neonorm; shares ahead 5% premarket
seekingalpha.com - April 7 at 10:32 AM
finance.yahoo.com logoJaguar and Napo Issue Commercial Updates
finance.yahoo.com - April 7 at 10:32 AM
streetinsider.com logoJaguar Animal Health (JAGX) Enters Merger Agreement with Napo Pharmaceuticals - StreetInsider.com
www.streetinsider.com - April 2 at 10:02 AM
streetinsider.com logoJaguar Animal Health (JAGX) Enters Merger Agreement with Napo Pharmaceuticals - StreetInsider.com
www.streetinsider.com - April 2 at 10:02 AM
streetinsider.com logoJaguar Animal Health (JAGX) Enters Merger Agreement with Napo Pharmaceuticals
www.streetinsider.com - March 31 at 6:03 PM
us.rd.yahoo.com logoJaguar Animal Health and Napo Pharmaceuticals Enter Definitive Merger Agreement
us.rd.yahoo.com - March 31 at 6:03 PM
thestreet.com logoJaguar Animal Health Stock Skyrocketing on Napo Pharma Merger
www.thestreet.com - March 31 at 6:03 PM
thestreet.com logoJaguar Animal Health Stock Rises on Napo Pharma Merger
www.thestreet.com - March 31 at 6:03 PM
thestreet.com logoAfter Clearing Valeant Litigation, Jaguar and Napo Pharmaceuticals Reunite
www.thestreet.com - March 31 at 6:03 PM
streetinsider.com logoJaguar Animal Health (JAGX) Enters Exclusive Evaluation Period With Multinational Animal Health Pharmaceutical ... - StreetInsider.com
www.streetinsider.com - March 30 at 8:08 AM
americanbankingnews.com logo Jaguar Animal Health Inc (JAGX) Receives Consensus Recommendation of "" from Brokerages
www.americanbankingnews.com - March 29 at 12:19 PM
reuters.com logoBRIEF-Jaguar Animal health-entered exclusive 60-day evaluation period
www.reuters.com - March 28 at 11:04 AM
streetinsider.com logoJaguar Animal Health (JAGX) Enters Exclusive Evaluation Period With Multinational Animal Health Pharmaceutical Firm Regarding Equilevia
www.streetinsider.com - March 28 at 11:04 AM
finance.yahoo.com logoJaguar Enters Exclusive Evaluation Period With Multinational Animal Health Pharmaceutical Firm Regarding Equilevia, Jaguar’s Drug Product Candidate for Equine Gastric Ulcer Syndrome
finance.yahoo.com - March 28 at 11:04 AM
americanbankingnews.com logoJaguar Animal Health Inc (JAGX) Short Interest Up 57.6% in March
www.americanbankingnews.com - March 28 at 8:23 AM
reuters.com logoBRIEF-Jaguar Animal Health says seeks mums designation for canalevia for exercise-induced diarrhea in dogs
www.reuters.com - March 14 at 11:44 AM
us.rd.yahoo.com logoJaguar Animal Health Seeks MUMS Designation for Canalevia for Exercise-Induced Diarrhea in Dogs
us.rd.yahoo.com - March 14 at 11:44 AM
finance.yahoo.com logoJaguar Animal Health to Participate in 29th Annual ROTH Conference the Week of March 13th in Orange County, California
finance.yahoo.com - March 3 at 5:59 PM
biz.yahoo.com logoJAGUAR ANIMAL HEALTH, INC. Files SEC form 8-K, Other Events
biz.yahoo.com - February 24 at 7:19 PM
biz.yahoo.com logoJAGUAR ANIMAL HEALTH, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - February 22 at 12:29 PM
reuters.com logoBRIEF-Jaguar Animal Health plans to launch prophylactic formulation of neonorm calf in powder form
www.reuters.com - February 16 at 9:56 PM
biz.yahoo.com logoJAGUAR ANIMAL HEALTH, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - February 15 at 9:11 PM
us.rd.yahoo.com logoStudy Supporting Herd-wide Reduction in Incidence and Severity of Diarrhea With Prophylactic Use of Neonorm Calf Published in Journal of Dairy Science
us.rd.yahoo.com - February 14 at 7:27 PM
biz.yahoo.com logoJAGUAR ANIMAL HEALTH, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure,
biz.yahoo.com - February 9 at 7:00 PM
seekingalpha.com logoJaguar Animal Health to merge with Napo Pharmaceuticals
seekingalpha.com - February 9 at 4:48 AM
streetinsider.com logoJaguar Animal Health (JAGX) to Merge with Napo Pharmaceuticals
www.streetinsider.com - February 9 at 4:48 AM
streetinsider.com logoJaguar Animal Health (JAGX) to Merge with Napo Pharmaceuticals - StreetInsider.com
www.streetinsider.com - February 8 at 11:46 PM
finance.yahoo.com logoJaguar Animal Health Enters Binding Agreement of Terms to Merge with Napo Pharmaceuticals
finance.yahoo.com - February 8 at 6:46 PM
finance.yahoo.com logoJaguar Animal Health Begins Entry Into Organic Market With Neonorm Calf
finance.yahoo.com - February 2 at 6:43 PM
rttnews.com logoJaguar Animal Health Signs With Elanco Global To Co-Promote Canalevia
www.rttnews.com - January 31 at 11:53 PM
streetinsider.com logoJaguar Animal Health (JAGX) Enters Collaboration with Eli Lilly (LLY) Subsidiary for Canalevia
www.streetinsider.com - January 31 at 11:53 PM
finance.yahoo.com logoJaguar Animal Health, Inc. (NAS:JAGX) Given Company Update by Aegis Capital Corp.
au.finance.yahoo.com - January 10 at 6:54 PM
us.rd.yahoo.com logoNapo Pharmaceuticals Secures $2 Million in Financing
us.rd.yahoo.com - January 3 at 11:26 AM
us.rd.yahoo.com logo9:02 am Jaguar Animal Health merger partner Napo Pharma obtains $2 mln in secured convertible debt financing from Kingdon Capital Management
us.rd.yahoo.com - January 3 at 11:26 AM
biz.yahoo.com logoJAGUAR ANIMAL HEALTH, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex
biz.yahoo.com - December 20 at 11:33 AM
seekingalpha.com logoSchein to distribute Jaguar's Neonorm Foal
seekingalpha.com - December 15 at 6:40 PM
reuters.com logoBRIEF-Jaguar Animal Health and Henry Schein sign distribution deal
www.reuters.com - December 14 at 4:31 AM
finance.yahoo.com logo9:07 am Jaguar Animal Health & Henry Schein (HSIC) sign an exclusive distribution agreement for Neonorm Foal; financial terms not disclosed
finance.yahoo.com - December 12 at 11:11 PM
finance.yahoo.com logoJaguar Animal Health and Henry Schein, Inc. Sign Exclusive Distribution Agreement for Neonorm Foal
finance.yahoo.com - December 12 at 10:48 AM
finance.yahoo.com logoJaguar Animal Health Exhibits Neonorm Foal at American Association of Equine Practitioners Annual Convention
finance.yahoo.com - December 9 at 9:46 AM
finance.yahoo.com logoJaguar Animal Health Gears Up for Secondary Offering
finance.yahoo.com - December 8 at 6:38 PM

Social

Chart

Jaguar Animal Health (JAGX) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by MarketBeat.com Staff